The PREDICT (increasing the participation of the elderly in clinical trials) study: The charter and beyond

Peter Crome, Antonio Cherubini, Joaquim Oristrell

Research output: Contribution to journalArticlepeer-review

Abstract

There is general agreement that the growth of the numbers of older people throughout the world has significant implications for both health and social care and for the prevention and treatment of disease and disability. The optimum use of pharmaceuticals and possibly nutraceuticals is, and will to a greater extent, therefore be of crucial importance. A snapshot of the current status of older people in relation to the issues discussed in this review is provided in an informative report published by Age UK.

Original languageEnglish
Pages (from-to)457-468
Number of pages12
JournalExpert Review of Clinical Pharmacology
Volume7
Issue number4
DOIs
Publication statusPublished - 2014

Keywords

  • cardiovascular disease
  • clinical trial
  • drug treatment
  • older people
  • patients view

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'The PREDICT (increasing the participation of the elderly in clinical trials) study: The charter and beyond'. Together they form a unique fingerprint.

Cite this